Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,972 public trials 2,027 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00004101

Conditions
Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations
  • Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Johns Hopkins Oncology Center Baltimore, Maryland, United States
  • Biologics Evaluation Section Bethesda, Maryland, United States
View Trial Details
Completed

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma

NCT00003595

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +14 more
Locations
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • San Francisco General Hospital Medical Center San Francisco, California, United States
  • Sylvester Cancer Center, University of Miami Miami, Florida, United States
View all 13 locations
View Trial Details
Completed

Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma

NCT00003575

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • San Francisco General Hospital Medical Center San Francisco, California, United States
  • Sylvester Cancer Center, University of Miami Miami, Florida, United States
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
View Trial Details

Related conditions